Method for simultaneously determining effective components in Shuanghuang toxin-vanquishing granules
Patent Information
- Application Number
- CN202411470504.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-08-12
- Filing Date
- 2024-10-21
- Publication Date
- 2024-11-29
AI Technical Summary
The thin layer chromatography detection method of Shuanghuang Baidu particles in the prior art is greatly affected by the ambient temperature and humidity and artificial operation. The results are difficult to determine, time-consuming and reagents, and the toxic developer is harmful to the experimenter, the operation is complicated, and it is reproduced. Poor sex.
Ultrasonic extraction and UPLC-PDA analysis method were used, and the 95vol% ethanol-0.1vol% phosphoric acid solution with low toxicity was used as the extraction agent. The berberine hydrochloride and chlorogenic acid in the Shuanghuangfeidu particles were used to measure the berberine hydrochloride and chlorogenic acid in the Shuanghuangfeidu particles through chromatogram and spectrogram. Qualitative and quantitative analysis of artemisolate, gallic acid, baicalin, baicalin, hambavin, forsythia and garicin were performed.
It realizes simple and rapid determination of the active ingredients in Shuanghuang Baidu particles, improves the measurement accuracy and reproducibility, reduces the risk of hazards for experimental personnel, shortens the detection time, and saves reagents and operating steps.
Smart Images

Figure CN119044372A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of detection of effective ingredients in veterinary drugs, and particularly relates to a method for simultaneously determining effective ingredients in Shuanghuang Baidu Granules. Background Art
[0002] Shuanghuang Baidu Granules is a Chinese veterinary medicine formula preparation, included in the Chinese medicine volume of "Veterinary Drug Quality Standard 2017 Edition" p106-108, the prescription is: 316g of Coptis chinensis, 316g of Scutellaria baicalensis, 916g of Astragalus membranaceus, 468g of Poria, 468g of Artemisia capillaris, 468g of Cnidium monnieri, 468g of Polygonatum sibiricum, 468g of Forsythia suspensa, 396g of Galla chinensis, 316g of Gardenia jasminoides, 200g of Curcuma zedoaria, and 200g of Trigonum gracile; the above 12 herbs are decocted 3 times, and the volatile oil is collected at the same time. The decoctions are combined and filtered. The filtrate is concentrated to a clear paste with a relative density of 1.10-1.15 (80°C), and divided into two equal parts. One part is spray-dried into an extract powder as the mother core for granulation, and the rest is used as a binder. Granulation, spraying with volatile oil, mixing, and making into 1000g. Shuanghuang Baidu Granules are brown to tan granules, which have the effects of clearing the lungs and detoxifying, invigorating Qi and strengthening the foundation, drying dampness and promoting bile secretion. They are mainly used to treat fever, coma, cough, asthma, diarrhea and other symptoms caused by excessive heat; they are widely used in intensive chicken farming enterprises.
[0003] There are 12 herbs in the quality standard of Shuanghuang Baidu Granules. In the original national standard method, berberine hydrochloride content determination was used as the standard, and thin layer chromatography was used for identification. The six thin layer chromatography methods were mainly used for identification of astragaloside I, cnidium monnieri, gallic acid, gardenia glycoside, berberine hydrochloride, and baicalin. The content determination used a mobile phase containing acetonitrile-1.36V% potassium dihydrogen phosphate solution-0.68V% sodium dodecyl sulfate solution (volume ratio of 100:50:50) as the mobile phase, the detection wavelength was 347nm, and the theoretical plate number calculated based on berberine hydrochloride was not less than 5000.
[0004] However, in the thin layer chromatography detection method of the national standard method, the spots are greatly affected by the ambient temperature and humidity and human operation, the spots are often unclear, the results are difficult to judge, and it is time-consuming and reagent-consuming. The inventor found in the actual inspection work that the developing agents used for chromatography, such as toluene, ethyl acetate, chloroform, methanol, isopropanol, benzene, butanol, etc., are highly toxic, causing great harm to the experimenters, and the operation is cumbersome and time-consuming. In addition, the thin layer chromatography detection of Shuanghuang Baidu Granules has complex preliminary preparations, requiring multiple steps such as unfolding, drying, and checking the results, which is time-consuming and laborious, and is greatly disturbed by factors such as ambient temperature and humidity, edge effects, etc., and the thin layer spots are sometimes difficult to distinguish by the method, and the reproducibility is poor. Summary of the invention
[0005] In view of the shortcomings of the prior art, the object of the present invention is to provide a method for simultaneously determining the effective ingredients in Shuanghuang Baidu Granules.
[0006] In order to achieve the above object, the present invention is implemented through the following technical solutions:
[0007] The first aspect of the present invention provides a method for simultaneously determining the effective ingredients in Shuanghuang Baidu Granules, comprising the following steps:
[0008] After mixing Shuanghuangbaidu granules with an extractant, ultrasonic extraction is performed, and the test solution is obtained by centrifugation and filtration; the test solution is analyzed by UPLC-PDA to obtain a chromatogram and a spectrum of the test solution;
[0009] The berberine hydrochloride, chlorogenic acid, scoparone, gallic acid, baicalin, baicalein, wogonin, forsythin and gardenia glycoside in Shuanghuang Baidu Granules are qualitatively and quantitatively analyzed simultaneously by the chromatogram and the spectrum;
[0010] The extractant is ethanol-phosphoric acid solution.
[0011] In some embodiments of the present invention, the chromatographic conditions of the UPLC-PDA analysis are:
[0012] The chromatographic column is HSS T3, 2.1 mm × 100 mm, 1.8 μm;
[0013] 3D scanning wavelength is 190-400nm;
[0014] 2D detection wavelengths are 210nm, 229nm, 232nm, 238nm, 278nm, 324nm, and 347nm;
[0015] Preferably, the 2D detection wavelength is 229nm, 238nm, 278nm, 324nm;
[0016] The mobile phase used was gradient elution;
[0017] Mobile phase A was 0.05 vol% phosphoric acid in acetonitrile, and mobile phase B was 0.05 vol% phosphoric acid in water.
[0018] In some embodiments of the present invention, the procedure of the gradient elution is, by volume percentage:
[0019]
[0020] In some embodiments of the present invention, the solid-to-liquid ratio of the Shuanghuangbaidu granules to the extractant is 4-16 g / L;
[0021] In the extractant, the volume ratio of ethanol to phosphoric acid is (50-75): (25-50);
[0022] The concentration of ethanol was 95 vol%, and the concentration of phosphoric acid was 0.1 vol%.
[0023] The inventors have found that methanol or methanol-hydrochloric acid is often used as an extractant in the current national standard thin-layer chromatography. In actual inspection work, it is found that the developing agent used for chromatography is highly toxic, which is relatively harmful to the experimenters, and the operation is cumbersome and time-consuming. The present invention selects a 95vol% ethanol-0.1vol% phosphoric acid solution with low toxicity as an extractant for extraction. The toxicity is low, the peak area response value of the compound is moderate, the sample treatment is simple, the reagent is saved, and the time is saved. The solvent used is safe and environmentally friendly to operate, and the harm to people and the environment is small. At the same time, in order to reduce the amount of organic solvent used in experimental consumables, the inventors also tried to use deionized water as the extractant of Shuanghuang Baidu Granules, but the extraction rates of various compounds are relatively low, and it is difficult to meet the test requirements.
[0024] In some embodiments of the present invention, the ultrasonic extraction time is 15-30 min; the centrifugal speed is 10000-15000 rpm / min, and the centrifugal time is 10-30 min; the filtration is through a microporous organic filter membrane; the microporous organic filter membrane is a 0.20-0.25 μm polytetrafluoroethylene microporous filter membrane;
[0025] Preferably, the ultrasonic extraction time is 15 minutes; the centrifugal speed is 12000 rpm / min, and the centrifugal time is 10 minutes; the microporous organic filter membrane is a 0.22 μm polytetrafluoroethylene microporous filter membrane.
[0026] In some embodiments of the present invention, the chromatographic conditions of the UPLC-PDA analysis further include a column temperature of 39-41°C;
[0027] The injection volume is 0.2-5 μL; preferably, the injection volume is 1-2 μL;
[0028] The flow rate of the mobile phase is 0.34-0.36 mL / min; preferably, the flow rate of the mobile phase is 0.35 mL / min.
[0029] In some embodiments of the present invention, it further includes:
[0030] Dissolve berberine hydrochloride, baicalin, baicalein, wogonin, forsythin, chlorogenic acid, scoparone, gardenia glycoside and gallic acid reference substances in ethanol or methanol to prepare reference substance solutions; then mix the reference substance solutions to prepare a reference substance mixed solution;
[0031] The reference substance mixed solution is subjected to UPLC-PDA analysis to obtain a chromatogram and a spectrum of the reference substance mixed solution;
[0032] According to the concentration, retention time, peak area in the spectrum and chromatogram of the reference mixed solution and the peak area of the test solution in the chromatogram, berberine hydrochloride, chlorogenic acid, scoparia lactone, gallic acid, baicalin, baicalein, wogonin, forsythiaside and gardeniaside in the test solution are qualitatively and quantitatively analyzed simultaneously.
[0033] In some embodiments of the present invention, in each of the reference solutions, the concentration of the gallic acid reference solution is 33.837-50.756 μg / mL; the concentration of the chlorogenic acid reference solution is 149.692-224.539 μg / mL; the concentration of the gardenia glycoside reference solution is 178.152-267.228 μg / mL; the concentration of the artemisinin reference solution is 133.278-199.918 μg / mL; the concentration of the berberine hydrochloride reference solution is 133.278-199.918 μg / mL; The concentration of the reference solution is 257.464-386.196 μg / mL; the concentration of the baicalin reference solution is 186.898-280.347 μg / mL; the concentration of the forsythiaside reference solution is 41.224-61.837 μg / mL; the concentration of the baicalein reference solution is 123.873-185.810 μg / mL; the concentration of the wogonin reference solution is 200.94-301.41 μg / mL;
[0034] Preferably, the concentration of the gallic acid reference solution is 42.297 μg / mL; the concentration of the chlorogenic acid reference solution is 187.116 μg / mL; the concentration of the gardenia glycoside reference solution is 222.69 μg / mL; the concentration of the artemisinin reference solution is 166.5986 μg / mL; the concentration of the berberine hydrochloride reference solution is 321.83 μg / mL; the concentration of the baicalin reference solution is 233.623 μg / mL; the concentration of the forsythiaside reference solution is 51.531 μg / mL; the concentration of the baicalein reference solution is 154.842 μg / mL; the concentration of the wogonin reference solution is 251.175 μg / mL;
[0035] Or, in the mixed solution of the reference substance, the concentration of gallic acid is 6.76-10.15 μg / mL; the concentration of chlorogenic acid is 14.96-22.45 μg / mL; the concentration of gardenia is 17.81-26.72 μg / mL; the concentration of scoparone is 10.66-15.99 μg / mL; the concentration of berberine hydrochloride is 25.744-38.616 μg / mL; the concentration of baicalin is 18.68-28.03 μg / mL; the concentration of forsythiaside is 8.24-12.37 μg / mL; the concentration of baicalein is 12.38-18.58 μg / mL; the concentration of wogonin is 4.01-6.02 μg / mL;
[0036] Preferably, in the reference substance mixed solution, the concentration of gallic acid is 8.46 μg / mL; the concentration of chlorogenic acid is 18.71 μg / mL; the concentration of gardenia is 22.27 μg / mL; the concentration of artemisinin is 13.33 μg / mL; the concentration of berberine hydrochloride is 32.18 μg / mL; the concentration of baicalin is 23.36 μg / mL; the concentration of forsythiaside is 10.31 μg / mL; the concentration of baicalein is 15.48 μg / mL; and the concentration of wogonin is 5.02 μg / mL.
[0037] In some embodiments of the present invention, the chromatographic conditions of the UPLC-PDA analysis further include:
[0038] The number of theoretical plates calculated for baicalin is 167,000, for artemisinin it is 110,000, for gallic acid it is 4,100, for chlorogenic acid it is 25,800, for gardeniain it is 46,800, forsythiain it is 188,000, and for berberine hydrochloride it is 139,000.
[0039] The second aspect of the present invention provides a method for detecting the quality of Shuanghuang Baidu Granules, which comprises using the method described in the first aspect to perform qualitative and quantitative analysis on berberine hydrochloride, chlorogenic acid, scoparone, gallic acid, baicalin, baicalein, wogonin, forsythiaside and gardeniaside in Shuanghuang Baidu Granules, comparing the results with the standard, and determining the quality of Shuanghuang Baidu Granules.
[0040] The beneficial effects of the present invention are:
[0041] (1) In the present invention, 9 main components in Shuanghuang Baidu Granules, including berberine hydrochloride in Coptis chinensis, baicalin, wogonin and baicalein in Scutellaria baicalensis, forsythin in Forsythia suspensa, chlorogenic acid and scoparone in Capillaris, geniposide in Gardenia jasminoides, and gallic acid in Galla chinensis, are determined at one time by liquid chromatography. The method is simple and rapid, has good separation effect, high determination accuracy, good result reproducibility, is easy to observe, has strong specificity, and has a good chromatographic peak shape. It not only meets the requirements of the Chinese Pharmacopoeia of Veterinary Medicine, but also saves time and reagents; thereby replacing most of the cumbersome thin-layer tests.
[0042] (2) The determination method of the present invention abandons methanol or methanol-hydrochloric acid as the extraction solvent in the original national standard thin layer chromatography, and instead selects 95% ethanol-0.1% phosphoric acid solution with low toxicity as the extraction solvent to extract the test sample. The toxicity is low, the peak area response value of the compound is moderate, the sample processing is simple, the reagent and time are saved, and the solvent used is safe and environmentally friendly to operate, and the harm to humans and the environment is small.
[0043] (3) The present invention abandons the salt-containing mobile phase in the original standard and adopts phosphoric acid to adjust the acidity of the mobile phase to prevent phosphate and sodium dodecyl sulfate from clogging the chromatographic column. Clogging not only shortens the life of the chromatographic column, but also often leads to increased pressure, thereby damaging the chromatograph pump and increasing the investment in repair and maintenance costs; and presents the results in the form of chromatograms and spectrograms, which is convenient and fast, the results are intuitive and easy to judge, and the detection limit is low, which greatly shortens the inspection time (from sample processing to on-machine inspection and product determination, the inspection can be completed in about 1.5 hours, while the original national standard multiple thin layer detection methods require 18-24 hours for one sample detection), thereby improving the inspection efficiency, detection sensitivity and inspection effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0045] Figure 1 is the spectrum of the reference solution in Example 1 of the present invention;
[0046] Figure 2 The chromatogram of the reference substance mixed solution in Example 1 of the present invention is 210 nm, and the injection volume is 2 μL;
[0047] Figure 3 The chromatogram of the reference substance mixed solution in Example 1 of the present invention is 229 nm, and the injection volume is 2 μL;
[0048] Figure 4 The chromatogram of the reference substance mixed solution in Example 1 of the present invention is 232 nm, and the injection volume is 2 μL;
[0049] Figure 5 The chromatogram of the reference substance mixed solution in Example 1 of the present invention is 238 nm, and the injection volume is 2 μL;
[0050] Figure 6 The chromatogram of the reference substance mixed solution in Example 1 of the present invention is 278 nm, and the injection volume is 2 μL;
[0051] Figure 7 The chromatogram of the reference substance mixed solution in Example 1 of the present invention is 324 nm, and the injection volume is 2 μL;
[0052] Figure 8 The chromatogram of the reference substance mixed solution in Example 1 of the present invention is 347 nm, and the injection volume is 2 μL;
[0053] Fig. 9 The chromatogram of Shuanghuang Baidu Granule 1 in Example 1 of the present invention is 210 nm, and the injection volume is 1 μL;
[0054] Fig.10 The chromatogram of Shuanghuang Baidu Granule 1 in Example 1 of the present invention is 229 nm, and the injection volume is 1 μL;
[0055] Fig.11 The chromatogram of Shuanghuang Baidu Granule 1 in Example 1 of the present invention is 232 nm, and the injection volume is 1 μL;
[0056] Fig.12 The chromatogram of Shuanghuang Baidu Granule 1 in Example 1 of the present invention is 238 nm, and the injection volume is 1 μL;
[0057] Fig.13 The chromatogram of Shuanghuang Baidu Granule 1 in Example 1 of the present invention is 278 nm, and the injection volume is 1 μL;
[0058] Fig.14 The chromatogram of Shuanghuang Baidu Granule 1 in Example 1 of the present invention is 324 nm, and the injection volume is 1 μL;
[0059] Fig.15 The chromatogram of Shuanghuang Baidu Granule 1 in Example 1 of the present invention is 347 nm, and the injection volume is 1 μL;
[0060] Fig.16 The chromatogram of Shuanghuang Baidu Granule 2 in Example 1 of the present invention is 229 nm, and the injection volume is 1 μL;
[0061] Fig.17 The chromatogram of Shuanghuang Baidu Granule 2 in Example 1 of the present invention is 238 nm, and the injection volume is 1 μL;
[0062] Fig.18 The chromatogram of Shuanghuang Baidu Granule 2 in Example 1 of the present invention is 278 nm, and the injection volume is 1 μL;
[0063] Fig.19 The chromatogram of Shuanghuang Baidu Granule 2 in Example 1 of the present invention is 324 nm, and the injection volume is 1 μL;
[0064] Fig. 20 The chromatogram of Shuanghuang Baidu Granule 3 in Example 1 of the present invention is 229 nm, and the injection volume is 1 μL;
[0065] Fig.21 The chromatogram of Shuanghuang Baidu Granule 3 in Example 1 of the present invention is 238 nm, and the injection volume is 1 μL;
[0066] Fig. 22 The chromatogram of Shuanghuang Baidu Granule 3 in Example 1 of the present invention is 278 nm, and the injection volume is 1 μL;
[0067] Fig.23 The chromatogram of Shuanghuang Baidu Granule 3 in Example 1 of the present invention is 324 nm, and the injection volume is 1 μL;
[0068] Fig.24 The chromatogram of the reference substance mixed solution in Example 2 of the present invention is 229 nm, and the injection volume is 1 μL;
[0069] Fig.25 This is the chromatogram of Shuanghuang Baidu Granules 3 in Example 2 of the present invention at 229 nm, with an injection volume of 1 μL. DETAILED DESCRIPTION
[0070] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.
[0071] The relevant information of the equipment, reagents, test solutions and reference solutions used in the following examples is as follows:
[0072] Instruments: BP211D analytical balance (Sartorius, Germany); Waters Acquity ultra-high performance liquid chromatograph (Waters, USA), PDA detector, chromatographic column: HSS T3 chromatographic column (2.1 mm×100 mm, 1.8 μm).
[0073] Test drugs: The test products are samples from enterprises for random inspection, produced by Jiangxi Zhongcheng Pharmaceutical Group Co., Ltd. and Shandong Fangzhou Biotechnology Co., Ltd. Phosphoric acid is of premium grade, ethanol and methanol are of chromatographic grade, and reference substances are mainly purchased from China Veterinary Drug Administration, China Food and Drug Inspection Institute, and China Institute of Biological Products.
[0074] Preparation of reference solution:
[0075] Berberine hydrochloride, baicalin, baicalein, wogonin, forsythin, chlorogenic acid, scoparone, and gallic acid reference substances were taken respectively, dissolved and fixed to volume with ethanol or methanol, and prepared into respective reference stock solutions; appropriate volumes of the reference stock solutions were mixed to obtain mixed reference stock solutions, as shown in Table 1 below.
[0076] Table 1 Detailed information on the preparation of the reference substance mixed solution
[0077]
[0078] Preparation of test sample solution: accurately weigh 0.2-0.4 g of Shuanghuang Baidu Granules test sample, place in a 25 mL-50 mL volumetric flask, dissolve with appropriate solvent and make up to the scale, weigh, ultrasonically extract for 15 min, weigh and make up the weight with appropriate solvent, accurately measure 5 mL, centrifuge at 12000 rpm / min for 10 min, filter with 0.22 um filter membrane, and use ultra-high performance liquid chromatography for determination. Table 2 shows the prepared test sample solution.
[0079] Table 2 Test sample solution
[0080]
[0081] The chromatographic conditions are:
[0082] The detector was a diode array detector, the chromatographic column was an HSS T3 chromatographic column, the column temperature was 39-41°C, the detection wavelength was 229 nm, the mobile phase A was acetonitrile (0.05% phosphoric acid), and the mobile phase B was 0.05% phosphoric acid solution; the flow rate was 0.35 mL / min; the mobile phase gradient elution program was shown in Table 3:
[0083] Table 3 Gradient elution program
[0084]
[0085] (1) Study on injection volume
[0086] Accurately pipette 0.2μL, 0.5μL, 1μL, 2μL, and 3μL of the reference solution into the HPLC, and perform gradient elution and detection under the above chromatographic conditions to qualitatively identify the sample by retention time and spectrum. Figure 2-Figure 8 As shown. The study found that when the injection volume was 0.2 μL, the reference solution sample responded well, but due to the relatively low content of some compounds in the sample, such as baicalin and scoparone, the response value was low, resulting in poor measurement accuracy. Therefore, the injection volume was 1-2 μL.
[0087] (2) Research on detection wavelength
[0088] The PDA detector was selected to collect multiple wavelengths simultaneously, and the 3D scanning wavelength was 190-400nm. Table 4 shows the spectral characteristic data of different compounds. Figure 1 The spectra of the corresponding different compounds are shown in Figure 2. By means of multi-channel scanning, detection channels with wavelengths of 210nm, 229nm, 232nm, 238nm, 278nm, 324nm, and 347nm are selected. It can be seen that the spectral characteristics of different compounds vary greatly, and their maximum absorption wavelengths are different. Among them, there are too many impurities interfering at 210nm; berberine hydrochloride responds well at 347nm, but baicalin, baicalein, and wogonin respond too low, but gallic acid, forsythiaside, and gardenia glycoside have no response; chlorogenic acid responds best at 324nm, but gallic acid has no response; baicalin, baicalein, and wogonin respond well at 278nm, but gardenia glycoside has no response. By comparing Table 4, it is found that the chromatographic peaks of the 9 compounds in the reference solution have good responses at 229nm, 232nm, and 238nm. Comprehensive qualitative identification will detect wavelengths, preferably 229nm, 238nm, 278nm, and 324nm.
[0089] Table 4 Spectral characteristic data of different compounds
[0090]
[0091] The chromatographic data information table of the reference mixed solution and Shuanghuang Baidu Granules 1-3 at a wavelength of 229nm is shown in Table 5. It can be seen from Table 5 that at 229nm, all 9 substances in the reference mixed solution were detected, and the separation degree, purity angle and purity threshold all met the requirements. The theoretical plate number can reach 167,000 based on baicalin, 110,000 based on artemisinin, 4,100 based on gallic acid, 25,800 based on chlorogenic acid, 46,800 based on gardenia glycoside, 188,000 based on forsythiaside, and 139,000 based on berberine hydrochloride. The chromatographic performance of this method is good.
[0092] In addition, from Table 5 and the chromatogram Figure 2-Figure 8 It can be seen that Shuanghuang Baidu Granules has no response at 324nm, which is the position corresponding to the retention time of the chlorogenic acid reference substance, but there are certain chromatographic peaks at wavelengths such as 229nm, 232nm, 238nm, and 278nm. After collecting its spectrum, it was found that it was inconsistent with the spectrum of chlorogenic acid, and the matrix interference was serious, so the chlorogenic acid compound was excluded from then on. Therefore, qualitative identification requires that the retention time and the spectrum are consistent to qualitatively identify a certain compound.
[0093] Table 5 Chromatographic data information of the reference substance mixed solution and Shuanghuang Baidu Granules 1-Shuanghuang Baidu Granules 3 at a wavelength of 229 nm
[0094]
[0095]
[0096]
[0097] From the data in Table 5, it can be seen that the sampling amount of 0.2g to 25ml volumetric flask can fully meet the requirements. Compared with the sampling amount of 0.4g to 50ml volumetric flask, the chromatographic response value is still good, and the volume ratio of the extractant ethanol is 75% higher than 50%, and the chromatographic peak area response value of most compounds is also improved. Compared with the samples of enterprise 1, the samples of enterprise 2 have much lower responses for some compounds, which proves the importance of supervision and random inspection. Different manufacturers have differences due to the gap in equipment size, performance and process level, as well as the different content of the original medicinal materials used. From another aspect, the development of this method can quickly detect the intrinsic quality of the granule product with one method and multiple tests, and can quickly test the production process verification and uniformity of the Shuanghuang Baidu Granules of the present invention, thereby improving the overall quality of the product.
[0098] The retention time, peak area, separation, symmetry, theoretical plate number and other chromatographic parameter information of the reference substance mixed solution and Shuanghuang Baidu Granules 1-Shuanghuang Baidu Granules 3 at different test wavelengths with an injection volume of 1-2 μL are shown in Tables 5-7. UPLC-PDA was used to determine the 9 main components in Shuanghuang Baidu Granules, including berberine hydrochloride in Coptis chinensis, baicalin, wogonin and baicalein in Scutellaria baicalensis, forsythin in Forsythia suspensa, chlorogenic acid and scoparone in Artemisia capillaris, geniposide in Gardenia jasminoides, and gallic acid in Galla chinensis, by liquid chromatography. The method is simple and rapid, with good separation effect, high determination accuracy, good result reproducibility, easy observation, strong specificity, and good chromatographic peak shape.
[0099] Table 6 Chromatographic data information of reference substance mixed solution at other multiple wavelengths Injection volume 2u l
[0100]
[0101]
[0102]
[0103] Table 7 Chromatographic data information of Shuanghuang Baidu Granules 1-3 at other multiple wavelengths Injection volume 1u l
[0104]
[0105]
[0106]
[0107]
[0108]
[0109]
[0110]
[0111] According to the concentration, retention time, peak area in the spectrum and chromatogram of the reference solution and the peak area in the chromatogram of the test solution, the berberine hydrochloride, chlorogenic acid, scoparone, gallic acid, baicalin, baicalein, wogonin, forsythin and gardenia glycoside in the test solution are qualitatively and quantitatively analyzed simultaneously. Figure 2-Figure 23 In the chromatogram of the positive sample of the test product, the same chromatographic peak appears at the corresponding position of the chromatogram of the 9 reference products, such as Figure 3As shown, the peak shape is good and the separation degree meets the standard, indicating that the target medicinal material can be detected. In addition, since the concentration of the compound is proportional to the peak area, quantitative calculation can be performed. The contents of various compounds in Shuanghuang Baidu Granules 1-Shuanghuang Baidu Granules 3 are shown in Table 8:
[0112] Table 8 Content of various compounds in Shuanghuang Baidu Granules 1-Shuanghuang Baidu Granules 3
[0113]
[0114]
[0115] From the chromatogram Figure 9-Figure 23 It can be seen that the responses of chlorogenic acid, artemisinin, baicalin, forsythin and wogonin are relatively low, and the contents are also relatively low; only the contents of gallic acid, berberine hydrochloride and baicalin are relatively high. The statistical table of content calculation results is shown in Table 8. The content of gallic acid is above 8 mg / g; and the content of baicalin is much lower than that of baicalin, chlorogenic acid is not detected, and the contents of artemisinin are very low.
[0116] In addition, the inventors compared the detection limits of the thin layer chromatography method using the original national standard and the liquid chromatography method used in the present invention, and the results are shown in Table 9. It is not difficult to see from Table 9 that the detection method of the present application has a faster detection speed for gallic acid, gardenia glycoside, baicalin, and berberine hydrochloride, and the detection limit is 20-500 times lower than the original national standard; at the same time, the detection method of the present application can detect baicalein, wogonin, chlorogenic acid, scoparone, and forsythin, and the detection limit is lower than 10ng, while the original national standard cannot detect the above substances, which shows that the detection method of the present application is simple and fast, has a good separation effect, and has high measurement accuracy.
[0117] Table 9 Detection limits of the original national standard and the liquid chromatography method used in the present invention
[0118]
[0119] Example 2
[0120] The difference from Example 1 is that the gradient elution program in the test conditions is changed, and the mobile phase A used is an acetonitrile solution of 0.05 vol% phosphoric acid, and the mobile phase B is a 0.05 vol% phosphoric acid aqueous solution; the specific elution program is shown in Table 10 below:
[0121] Table 10 Comparative Example 1 Gradient elution program
[0122]
[0123] Under the condition of 229nm, the reference substance mixed solution and Shuanghuang Baidu Granule 3 were tested. The test results are shown in Table 11 and the chromatogram is shown in the attached figure. Fig.24 and 25 shown.
[0124] Table 11 Chromatographic data of reference substance mixed solution and Shuanghuangbaidu granules 3
[0125]
[0126] Chromatographic data of Shuanghuang Baidu Granule 3
[0127]
[0128]
[0129] From the chromatogram Figure 24-25 It can be seen that the matrix interference of chlorogenic acid, scoparone, baicalin, and forsythin in Shuanghuang Baidu Granule 3 is relatively large, the separation is relatively poor, and the symmetry factor of multiple compounds is also relatively poor, which is difficult to meet the test requirements. Therefore, the method of Example 2 was abandoned. After countless repeated adjustments of the gradient elution program, further optimization, the chromatographic conditions of Example 1 were formed.
[0130] In addition, in order to reduce the amount of organic solvents used in the experiment, water was also tested as the extraction agent for Shuanghuangbaidu Granules, but the extraction rates of various compounds were relatively low. Finally, water was abandoned as the extraction solvent.
[0131] In addition, the inventors have found that in the process of production process extraction and granulation, due to various factors such as repeated heating extraction, it may be converted into other similar compounds, or the medicinal materials used to save costs have problems themselves, and the original content of multiple compounds is very low, coupled with the continuous loss during processing and other reasons, the content of the finished granules is low, and the method can be used as a rapid screening method for continuous process improvement to further optimize the production process; or because of the difference in the original medicinal materials used, such as the Pharmacopoeia, Artemisia capillaris is divided into Cotton Artemisia capillaris and Flower Artemisia capillaris, the main detection index of Cotton Artemisia capillaris is chlorogenic acid, and the main detection index of Flower Artemisia capillaris is artemisia lactone. Through the present invention, it can also be seen which kind of Artemisia capillaris medicinal material is used when feeding Shuanghuang Baidu Granules. In addition, the research of the present invention mainly lays the foundation for the revision of the Shuanghuang Baidu Granules Veterinary Pharmacopoeia Standard in 2025. It is recommended to increase the content determination of gallic acid when the Pharmacopoeia Standard is formulated and revised in 2025. The method is pre-treated by self-made samples and increasing the sample size of Shuanghuang Baidu Granules from multiple enterprises, and various chromatographic conditions are further optimized to increase the detection of characteristic spectra.
[0132] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for simultaneously determining the effective ingredients in Shuanghuang Baidu Granules, characterized in that: The steps include: After mixing Shuanghuangbaidu granules with an extractant, ultrasonic extraction is performed, and the test solution is obtained by centrifugation and filtration; the test solution is analyzed by UPLC-PDA to obtain a chromatogram and a spectrum of the test solution; The berberine hydrochloride, chlorogenic acid, scoparone, gallic acid, baicalin, baicalein, wogonin, forsythin and gardenia glycoside in Shuanghuang Baidu Granules are qualitatively and quantitatively analyzed simultaneously by the chromatogram and the spectrum; The extractant is ethanol-phosphoric acid solution.
2. The method according to claim 1, characterized in that The chromatographic conditions of the UPLC-PDA analysis were as follows: the chromatographic column was HSS T3, 2.1 mm × 100 mm, 1.8 μm; 3D scanning wavelength is 190-400nm; 2D detection wavelength is 210nm, 229nm, 232nm, 238nm, 278nm, 324nm or 347nm; Preferably, the 2D detection wavelength is 229nm, 238nm, 278nm or 324nm; The mobile phase used was gradient elution; Mobile phase A was 0.05 vol% phosphoric acid in acetonitrile, and mobile phase B was 0.05 vol% phosphoric acid in water.
3. The method according to claim 2, characterized in that In volume percentage, the procedure of the gradient elution is:
4. The method according to claim 1, characterized in that The solid-to-liquid ratio of the Shuanghuangbaidu granules to the extractant is 4-16 g / L; In the extractant, the volume ratio of ethanol to phosphoric acid is (50-75): (25-50); The concentration of ethanol was 95 vol%, and the concentration of phosphoric acid was 0.1 vol%.
5. The method according to claim 1, characterized in that The ultrasonic extraction time is 15-30min; the centrifugal speed is 10000-15000rpm / min, and the centrifugal time is 10-30min; the filtration is through a microporous organic filter membrane; the microporous organic filter membrane is a 0.20-0.25μm polytetrafluoroethylene microporous filter membrane; Preferably, the ultrasonic extraction time is 15 minutes; the centrifugal speed is 12000 rpm / min, and the centrifugal time is 10 minutes; the microporous organic filter membrane is a 0.22 μm polytetrafluoroethylene microporous filter membrane.
6. The method according to claim 2, characterized in that The chromatographic conditions of the UPLC-PDA analysis also include: a column temperature of 39-41°C; an injection volume of 0.2-5 μL; preferably, the injection volume is 1-2 μL; The flow rate of the mobile phase is 0.34-0.36 mL / min; preferably, the flow rate of the mobile phase is 0.35 mL / min.
7. The method according to claim 1, characterized in that Also includes: Dissolve berberine hydrochloride, baicalin, baicalein, wogonin, forsythin, chlorogenic acid, scoparone, gardenia glycoside and gallic acid reference substances in ethanol or methanol to prepare reference substance solutions; then mix the reference substance solutions to prepare a reference substance mixed solution; The reference substance mixed solution is subjected to UPLC-PDA analysis to obtain a chromatogram and a spectrum of the reference substance mixed solution; According to the concentration, retention time, peak area in the spectrum and chromatogram of the reference mixed solution and the peak area of the test solution in the chromatogram, berberine hydrochloride, chlorogenic acid, scoparia lactone, gallic acid, baicalin, baicalein, wogonin, forsythiaside and gardeniaside in the test solution are qualitatively and quantitatively analyzed simultaneously.
8. The method according to claim 7, characterized in that In the reference solution, the concentration of the gallic acid reference solution is 33.837-50.756 μg / mL; the concentration of the chlorogenic acid reference solution is 149.692-224.539 μg / mL; the concentration of the gardenia glycoside reference solution is 178.152-267.228 μg / mL; the concentration of the artemisinin reference solution is 133.278-199.918 μg / mL; the concentration of the berberine hydrochloride reference solution is The concentration is 257.464-386.196μg / mL; the concentration of baicalin reference solution is 186.898-280.347μg / mL; the concentration of forsythiaside reference solution is 41.224-61.837μg / mL; the concentration of baicalein reference solution is 123.873-185.810μg / mL; the concentration of wogonin reference solution is 200.94-301.41μg / mL; Preferably, the concentration of the gallic acid reference solution is 42.297 μg / mL; the concentration of the chlorogenic acid reference solution is 187.116 μg / mL; the concentration of the gardenia glycoside reference solution is 222.69 μg / mL; the concentration of the artemisinin reference solution is 166.598 μg / mL; the concentration of the berberine hydrochloride reference solution is 321.83 μg / mL; the concentration of the baicalin reference solution is 233.623 μg / mL; the concentration of the forsythiaside reference solution is 51.531 μg / mL; the concentration of the baicalein reference solution is 154.842 μg / mL; the concentration of the wogonin reference solution is 251.175 μg / mL; Or, in the mixed solution of the reference substance, the concentration of gallic acid is 6.76-10.15 μg / mL; the concentration of chlorogenic acid is 14.96-22.45 μg / mL; the concentration of gardenia is 17.81-26.72 μg / mL; the concentration of scoparone is 10.66-15.99 μg / mL; the concentration of berberine hydrochloride is 25.744-38.616 μg / mL; the concentration of baicalin is 18.68-28.03 μg / mL; the concentration of forsythiaside is 8.24-12.37 μg / mL; the concentration of baicalein is 12.38-18.58 μg / mL; the concentration of wogonin is 4.01-6.02 μg / mL; Preferably, in the reference substance mixed solution, the concentration of gallic acid is 8.46 μg / mL; the concentration of chlorogenic acid is 18.71 μg / mL; the concentration of gardenia is 22.27 μg / mL; the concentration of artemisinin is 13.33 μg / mL; the concentration of berberine hydrochloride is 32.18 μg / mL; the concentration of baicalin is 23.36 μg / mL; the concentration of forsythiaside is 10.31 μg / mL; the concentration of baicalein is 15.48 μg / mL; and the concentration of wogonin is 5.02 μg / mL.
9. The method according to claim 2, characterized in that The chromatographic conditions of the UPLC-PDA analysis also include: the theoretical plate number is 167,000 when calculated with baicalin, 110,000 when calculated with scoparia lactone, 4,100 when calculated with gallic acid, 25,800 when calculated with chlorogenic acid, 46,800 when calculated with gardenia glycoside, 188,000 when calculated with forsythiaside, and 139,000 when calculated with berberine hydrochloride.
10. A method for quality detection of Shuanghuang Baidu Granules, comprising: using the method described in any one of claims 1 to 9 to perform qualitative and quantitative analysis on berberine hydrochloride, chlorogenic acid, scoparone, gallic acid, baicalin, baicalein, wogonin, forsythiaside and gardeniaside in Shuanghuang Baidu Granules, comparing the results with the standard to determine the quality of Shuanghuang Baidu Granules.
